科伦急了？业绩下滑后75岁“大胸肌”董事长代言自家抗衰新品

Core Viewpoint - Kelong Pharmaceutical is entering the health and wellness sector with a focus on ergothioneine, a compound believed to have significant anti-aging properties, as indicated by the company's chairman, Liu Gexin [1][5]. Company Overview - Kelong Pharmaceutical was founded in 1996 by Liu Gexin, who has served as chairman since its inception [1]. - The company has faced challenges in its traditional pharmaceutical business, including a decline in demand for infusion products and increased competition in the generic drug market [4]. - Kelong Pharmaceutical's revenue for Q1 2025 was 4.39 billion yuan, a decrease of 29.42% year-on-year, with net profit dropping by 43.07% to 584 million yuan [4]. Product Development - The upcoming ergothioneine product is set to launch in mid-May, coinciding with Kelong's 29th anniversary [1]. - The raw materials for ergothioneine are supplied by Kelong's subsidiary, Chuaning Bio, which specializes in biotechnological products [2]. - Ergothioneine is reported to have seven health benefits, including anti-aging, sleep improvement, cognitive enhancement, skin health, anti-inflammation, diabetes prevention, and cardiovascular protection [2]. Marketing Strategy - Kelong has established a sales platform named Kelong Yongnian, which is primarily responsible for marketing health products [4]. - The company aims to leverage the personal endorsement of its 75-year-old chairman to enhance the product's market appeal [5]. - Kelong is preparing to launch over ten anti-aging products, indicating a strategic shift towards health and wellness [5]. Industry Context - The health and wellness market is seen as a promising growth area, particularly in anti-aging products, which are gaining traction among consumers [1][5]. - Kelong's entry into this sector reflects a broader trend in the pharmaceutical industry, where companies are diversifying their offerings to adapt to changing market demands [4].